Ask AI
Bill114th CongressFiled Jun 23, 2016Health
S. 3094

PRICED Act

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary introduced in senate (Jun 23, 2016)

Price Relief, Innovation, and Competition for Essential Drugs Act or the PRICED Act

This bill amends the Public Health Service Act to allow biosimilars to be marketed seven years after the reference brand name biological product is licensed. Currently, brand name biological products are provided a 12-year marketing exclusivity period.

This shortened marketing exclusivity period applies only to biological products licensed by the Food and Drug Administration after enactment of this bill.

What just happenedJun 23, 2016

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Sen. Brown, Sherrod [D-OH](D-OH)Sponsor
1 cosponsor1 R
Read on Congress.gov
1cosponsors1committees2actions1related bills3subjects
  1. Jun 23, 2016IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. Jun 23, 2016IntroReferral10000

    Introduced in Senate

PRICED Act — Informed